BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 865618)

  • 1. Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes.
    Anwyl R; Appel SM; Narahashi T
    Nature; 1977 May; 267(5608):262-3. PubMed ID: 865618
    [No Abstract]   [Full Text] [Related]  

  • 2. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
    Bevan S; Kullberg RW; Heinemann SF
    Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
    [No Abstract]   [Full Text] [Related]  

  • 3. Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins.
    Appel SH; Anwyl R; McAdams MW; Elias S
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2130-4. PubMed ID: 266734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum.
    Harvey AL; Robertson JG; Barkas T; Harrison R; Lunt GG; Stephenson FA; Campbell MJ; Teague RH
    Clin Exp Immunol; 1978 Dec; 34(3):411-6. PubMed ID: 743809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation.
    Kao I; Drachman DB
    Science; 1977 Apr; 196(4289):527-9. PubMed ID: 850793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of acetylcholine receptor by antibody against the receptor.
    Heinemann S; Bevan S; Kullberg R; Lindstrom J; Rice J
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3090-4. PubMed ID: 268657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins.
    Ashizawa T; Appel SH
    Neurology; 1985 Dec; 35(12):1748-53. PubMed ID: 4069366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Myasthenia gravis: relationship between serum factor blocking acetylcholine receptors and anti-striated-muscle antibody.
    Ringel SP; Bender AN; Engel WK; Smith HJ
    Lancet; 1975 Jun; 1(7921):1388. PubMed ID: 48981
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.
    Namba T; Grob D
    Neurology; 1968 Mar; 18(3):273. PubMed ID: 5689669
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process.
    Drachman DB; Angus CW; Adams RN; Kao I
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3422-6. PubMed ID: 277944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia gravis symptoms in rabbits after development of antibodies against acetylcholine receptors].
    Heilbronn E; Hilton-Brown P; Mattsson C; Stålberg E
    Lakartidningen; 1975 Apr; 72(15):1558-60. PubMed ID: 1134154
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Acetylcholine-receptor-blocking factor and striated-muscle antibody in myasthenia gravis.
    Strauss AJ
    Lancet; 1976 Jun; 1(7974):1405-6. PubMed ID: 59037
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoclonal antibodies modify acetylcholine-induced ionic channel properties in cultured chick myoballs.
    Goldberg G; Mochly-Rosen D; Fuchs S; Lass Y
    J Membr Biol; 1983; 76(2):123-8. PubMed ID: 6315946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Cause of weakness in myasthenia gravis.
    Grob D
    N Engl J Med; 1976 Mar; 294(13):722-3. PubMed ID: 1082544
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in tetrodotoxin-resistant action potentials after passive transfer of myasthenia gravis patient sera.
    Losavio A; Muchnik S; Sica RE; Panizza M
    J Neurol Sci; 1989 Jul; 91(3):345-51. PubMed ID: 2769300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.
    Kao I; Drachman DB
    Science; 1977 Jan; 195(4273):74-5. PubMed ID: 831257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.